NCT04119024 2026-03-17
Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors
Stanford University
Phase 1 Recruiting
Clinical Trials
19 trialsNCT05764954 2025-09-04
A Study of Tumor-Treating Fields (TTFields) in People With Lung Adenocarcinoma
Memorial Sloan Kettering Cancer Center
Phase 1 Recruiting
NCT03054298 2025-04-29
CAR T Cells in Mesothelin Expressing Cancers
University of Pennsylvania
Phase 1 Completed
NCT06602661 2024-09-19
Reinforced and Non-Reinforced Staple Lines in Fissureless Lobectomy
Surrey Thoracic Surgery Group
Phase 1 Not yet recruiting
NCT00526461 2023-08-04
Photodynamic Therapy Using HPPH in Treating Patients With Stage 0 Non-Small Cell Lung Cancer
Roswell Park Cancer Institute
Phase 1 Completed
NCT02120807 2023-01-26
Certolizumab in Combination With Chemotherapy for Patients With Stage IV Lung Adenocarcinomas
Memorial Sloan Kettering Cancer Center
Phase 1 Completed
NCT01302808 2021-01-20
Romidepsin and Erlotinib Hydrochloride in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer
University of Texas Southwestern Medical Center
Phase 1 Completed
NCT01958372 2020-11-23
Radiation Therapy, Chemotherapy, and Soy Isoflavones in Treating Patients With Stage IIIA-IIIB Non-Small Cell Lung Cancer
Barbara Ann Karmanos Cancer Institute
Phase 1 Completed
NCT00986297 2020-08-20
Specialized Radiation Therapy in Treating Patients With Stage II, Stage III, Stage IV, or Recurrent Non-Small Cell Lung Cancer and Poor Performance Status
University of Texas Southwestern Medical Center
Phase 1 Completed
NCT00003002 2019-02-27
HER-2/Neu Vaccine Plus GM-CSF in Treating Patients With Stage III or Stage IV Breast, Ovarian, or Non-small Cell Lung Cancer
University of Washington
Phase 1 Completed
NCT00287963 2018-05-17
Topotecan and Vinorelbine in Treating Patients With Recurrent Lung Cancer
Medical University of South Carolina
Phase 1 Completed
NCT00005023 2017-11-30
Vaccine Therapy Plus Sargramostim in Treating Patients With Stage III or Stage IV Cancer
University of Washington
Phase 1 Completed
NCT00310154 2017-05-30
Gefitinib, Docetaxel, and Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer
Wake Forest University Health Sciences
Phase 1 Completed
NCT00009789 2016-07-14
Radiation Therapy in Treating Patients With Stage I Non-Small Cell Lung Cancer And Lung Dysfunction
Alliance for Clinical Trials in Oncology
Phase 1 Completed
NCT02691871 2016-02-25
Apatinib Plus Docetaxel as 2nd Line Treatment in Patients With Advanced Lung Adenocarcinoma Harboring Wild-type EGFR
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 1 Unknown
NCT02059967 2015-03-19
Phase I IGART Study Using Active Breathing Control and Simultaneous Boost for Patients With NSCLC
Virginia Commonwealth University
Phase 1 Withdrawn
NCT01668823 2014-07-31
Photodynamic Therapy in Treating Patients With Lung Cancer
Roswell Park Cancer Institute
Phase 1 Completed
NCT00005630 2013-06-19
Vaccine Therapy and Sargramostim in Treating Patients With Non-small Cell Lung Cancer
Memorial Sloan Kettering Cancer Center
Phase 1 Completed
NCT00025571 2011-03-07
Photodynamic Therapy With HPPH in Treating Patients With Non-Small Cell Lung Cancer
Roswell Park Cancer Institute
Phase 1 Completed